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Dlchloroacetate Impairs Energy Metabolism and
Produces a Negative Inotropic Effect In Vascular
Smooth Muscle
John T. Barron. Joseph E. Parrillo. Rush Medical College. Chicago, IL
Dichloroacetate (DCA) is a promising agent for treatment of congestive heart
failure. By stimulation of pyruvate dehydrogenase, it facilitates the oxidation
of glucose land its metabolites pyruvate and lactate), decreases 02 con-
sumption, and optimizes efficiency of energy production by heart muscle.
Its effect on the energy metabolism of vascular smooth muscle. however, is
unknown. The effect of DCA on vascular smooth muscle was investigated
in segments of porcine carotid arteries mounted in an organ bath and incu-
bated in physiological salt solution (PSS) containing glucose and presence
or absence of 1 mM DCA.
DCA suppressed the production of lactic acid (0.03 ± 0.006 vs. 0.11 ±
0.01 /Lmol!g/min.; p < 0.001, n = 8) and the level of pyruvate was reduced
by 56% Ip < 0.01) consistent with enhanced oxidation of glucose. However,
02 consumption was unaffected. The levels of the Krebs cycle metabolites
citrate and oxaloacetate were unaltered by DCA but aspartate and oxoglu-
tarate were decreased by 66% (p < 0.005) and 30% (p < 0.02) respectively,
suggesting increased Krebs cycle activity. Despite this, the level of ATP +
Phosphocreatine was decreased by DCA 11.00 ± 0.09 vs. 1.40 ± 0.09 /Lmol!g,
p < 0.02. n = 8). DCA had no effect on high energy phosphate levels in con-
trol carotid arteries incubated in glucose-free PSS containing fatty acid (0.5
mM octanoate). Carotid arteries incubated in DCA and then stimulated to
contract by K+-depolarization displayed a reduced rate of tension genera-
tion when compared with controls Ip < 0.05, n = 17).
It is concluded that, in contrast to cardiac muscle, DCA impairs energy
metabolism and exerts a negative inotropic effect in vascular smooth mus-
cle in vitro. The impairment in energy metabolism is related to altered activ-
ity of the Krebs cycle as a result of excessive oxidation of glucose. Whether
this effect on glucose metabolism and contractility of vascular smooth mus-
cle occurs in vivo requires further investigation. The effects of DCA on the
peripheral vasculature may playa role in its beneficial effects in congestive
heart failure.
tive FFR in NF becomes negative (p < 0.01). CPA reduced isometric force of
contraction and peak rate of tension decay, and prolonged time to half relax-
ation (p < 0.05). In conclusion: (1 }the SR-Ca2+-ATPase plays a functional role
for the positive FFR in man; (2) the altered FFR in failing human myocardium
may be due to an altered SR-Ca2+-ATPase-function.
The Hypotensive Effect of the Angiotensin II
Antagonist EXP 3174 Depends upon the
Renin-Angiotensin System Activation In
Conscious Dogs with Heart Failure
Fabrice Barbe, Jinbo Su, Thanh Tam Guyenne, Monique Laplace, Joel Menard,
Bertrant Crozatier, Luc Hittinger. INSERM U400 Creted and U367 Paris, France
Since the renin-angiotensin system exerts deleterious effects in heart fail-
ure, angiotensin II antagonists are considered as a potential therapy in heart
failure. Therefore. the acute hemodynamic effects of the angiotensin II antag-
onist EXP 3174 (EXP, 0.1 mglkg) were compared to those of the angiotensin
converting enzyme inhibitor enalaprilat (E. 1 mg/kg) in 14 chronically instru-
mented conscious dogs with heart failure induced by right ventricular pacing
(240 bpm, 3 weeks). When all dogs were considered as one group, E low-
ered mean arterial pressure (MAP) by 14 ± 2 mmHg while EXP lowered MAP
by 8 ± 2 mmHg (p < 0.05 vs E). The fall in MAP after EXP was correlated
with the baseline plasma angiotensin" level (r = 0.731. When dogs were
grouped according to their baseline plasma levels of the renin-angiotensin
system activity, dogs with low activation of the renin-angiotensin system (n
= 7) had a greater fall in MAP during E (14 ± 3 mmHg) than during EXP (2
± 1 mmHg). Additional doses of E or EXP did not produce further changes.
However, in dogs with marked activation of the renin-angiotensin system (n
= 7) falls in MAP were not significantly different following E or EXP (E:14 ±
3 vs EXP: 13 ± 3 mmHg),
Thus, in this model of heart failure, the angiotensin" antagonist EXP 3174
exerts potent acute hemodynamic effects. However, in contrast to Enalapri-
lat, the hypotensive effect of EXP 3174 depends upon the activation level of
the renin-angiotensin system.
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MCI·154, a Novel Calcium Sensitizer, Has
Beneficial Hemodynamic Effects In
Pacing-Induced Heart Failure
Shinobu Teramura. Tetsu Yamakado. Mitsugu Maeda, Chikaya Oomichi.
Takeshi Nakano. The 1st Dept. otlnt Med, Mie University. Tsu, Japan
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To assess the efficacy of MCI-154 (MCI), a new cardiotonic agent with cal-
cium (Ca2+) sensitizing action, on left ventricular (LV) function in heart fail-
ure (HF), we studied nine anesthetized dogs before (C) and after pacing-
induced HF (245bpm for 2-4 weeks). LV cineangiography and pressure
(P) (tip-manometer) were obtained before and during infusion of MCI (1.0
/Lglkg/min for 15 min) in C and HF. Results. Heart rate (HR) and LV systolic
pressure were unchanged with MCI. MCI augmented LV systolic function
assessed by ejection fraction IEF) and end-systolic P-volume ratio (Ees) eval-
uated by IVC occlusion. MCI also augmented LV relaxation assessed by the
time constant (Tau) of LVP decay in both C and HF. However, inotropic and
lusitropic effects of MCI were more striking in HF than in C as follows:
'p < 0.05. "p < 0.01
Conclusion. Mel exerts its potent inotropic activity in HF. In addition, de-
spite the effect of myofilament sensitization to Ca2+. MCI improves LV re-
laxation in HF more than in C without HF. MCI may be a useful agent in the
treatment of HF.
11014-100 IIncrease in Ventricular Adrenomedullln In the
Failing Human Heart
Michihisa Jougasaki. Chi-Ming Wei. John C. Burnett Jr.. Cardiorenal Research,
Mayo Clinic, Rochester. MN
Adrenomedullin (ADM) is a newly discovered vasoactive peptide which may
play an important role in cardiovascular regulation. Based upon the reports
that ADM mRNA and ADM-like immunoreactivity are present in the heart.
as well as the report that ADM stimulates cAMP generation, the present
study was designed to investigate the immunohistochemical localization of
ADM in the normal and failing human heart. Human cardiac tissues were
obtained from five patients with end-stage heart failure undergoing cardiac
transplantation. Five normal donor hearts Which were used for cardiac trans-
plantation served as a source for normal atrial tissues. Normal ventricular
myocardium was also obtained by endomyocardial biopsy from the right
ventricles of these donor hearts immediately before cardiac transplantation.
Immunohistochemical examination revealed positive immunostaining within
the myocardia in both atria and ventricles of healthy and severely failing hu-
man hearts. and which was more intense in the atria than in the ventricles.
Although there were no significant difference in the intensity of immunore-
activity between normal and failing atria. ADM immunoreactivity was signifi-
cantly intense in the ventricular myocytes from failing hearts as compared to
normals. No immunostaining was observed in endocardium. epicardium. en-
dothelium or connective tissue. Control slides with nonimmune rabbit serum
(NRS) and immunoabsorbed antibody were negative for ADM immunoreac-
tivity. This study demonstrates that ADM is present in the human heart and
that its immunoreactivity is markedly increased in the failing human ventricle.
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Although several recent studies have demonstrated that elderly patients (pts)
with CAD are at higher risk of silent ischemia (Sl), relatively little information is
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Coronary Artery Disease in the Elderly
Silent Ischemia During Daily Life is an
Independent Predictor of Poor Clinical Outcome
and Increased Risk of Cardiac Death
Prakash C. Deedwanla, Enrique V. Carbajal, James Oakley. VAMC-Fresno, UCSF
School of Medicine, San Francisco, CA
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Ca2+ -Uptake of Sarcoplasmic Reticulum Plays a
Functional Role for the Force-Frequency
Relationship In Man
Robert H.G. Schwinger, Ulrich Schmidt, Udo Bavendiek, Erland Erdmann. Khnik III
fiir Innere Medizin, K61n, Germany
Cyclopiazonic acid (CPA). a mycotoxin from Aspergillus and Penicillium.
is a highly selective inhibitor of the Ca2+-ATPase in sarcoplasmic reticu-
lum (SR). The present study aimed to investigate the functional role of
the Ca2+-ATPase for the force-frequency-relationship (FFR) in human my-
ocardium. The effect of CPA (0.01-30 /LM) on Ca2+-uptake (45Ca2+) and
Ca2+-ATPase ([free Ca2+] 1.5 nM-1.5 /LM) on SR-vesicles (left ventricle) as
well as on the FFR (0.5-3 Hz, left ventricular papillary muscle strips) in the
very same human nonfailing hearts (NF. donor hearts, n = 10) was examined.
CPA concentration-dependently inhibited SR Ca2+-uptake and Ca2+-ATPase
(EC50 : 0.3 I'M) (p < 0.05). In the presence of CPA (100 I'M) the former posi-
